Cases 1 - 10 of 22
Astrazeneca AB et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv01457
Plaintiff:
Astrazeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
GREENE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22298
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
NATHANIEL GREENE
Defendant:
AUROBINDO PHARMA, LTD., SCIEGEN PHARMACEUTICALS, INC., U.S., WESTMINSTER PHARMACEUTICALS and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bristol-Myers Squibb Company et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00393
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv00335
Plaintiff:
Bayer Intellectual Property GMBH, Bayer Pharma AG, Bayer AG and others
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GRAY v. AUROBINDO PHARMA LTD. et al
as 1:2022cv06153
Plaintiff:
LOUISE GRAY
Defendant:
AUROBINDO PHARMA LTD., AUROBINDO PHARMA U.S.A., INC., SCIEGEN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1446 pl Notice for Removal - Product Liability
THOMSON v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06111
Plaintiff:
Beverly Thomson
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Gray v. Aurobindo Pharma Ltd. et al
as 1:2022cv02353
Plaintiff:
Louise Gray
Defendant:
Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Sciegen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1446 Notice of Removal
KNUDSON v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv04813
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
MARY ANN KNUDSON
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, ACETERIS, LLC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. v. ScieGen Pharmaceuticals, Inc. et al
as 1:2021cv01616
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
ScieGen Pharmaceuticals, Inc. and Bactolac Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
